Microbio Co., Ltd. (TPEX:4128)

Microbio Statistics

Total Valuation

Microbio has a market cap or net worth of TWD 13.91 billion. The enterprise value is 13.34 billion.

Market Cap	13.91B
Enterprise Value	13.34B

Important Dates

The last earnings date was Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Microbio has 588.17 million shares outstanding. The number of shares has decreased by -0.12% in one year.

Current Share Class	588.17M
Shares Outstanding	588.17M
Shares Change (YoY)	-0.12%
Shares Change (QoQ)	-1.37%
Owned by Insiders (%)	0.08%
Owned by Institutions (%)	6.38%
Float	428.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.67
PB Ratio	1.34
P/TBV Ratio	1.56
P/FCF Ratio	19.60
P/OCF Ratio	18.57
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.95
EV / Sales	7.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	18.79

Financial Position

The company has a current ratio of 6.20, with a Debt / Equity ratio of 0.05.

Current Ratio	6.20
Quick Ratio	5.70
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	0.81
Interest Coverage	-38.38

Financial Efficiency

Return on equity (ROE) is -12.91% and return on invested capital (ROIC) is -2.10%.

Return on Equity (ROE)	-12.91%
Return on Assets (ROA)	-1.95%
Return on Invested Capital (ROIC)	-2.10%
Return on Capital Employed (ROCE)	-3.49%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.14
Inventory Turnover	5.67

Taxes

In the past 12 months, Microbio has paid 171,000 in taxes.

Income Tax	171,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.52% in the last 52 weeks. The beta is 0.60, so Microbio's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-32.52%
50-Day Moving Average	23.94
200-Day Moving Average	29.32
Relative Strength Index (RSI)	47.12
Average Volume (20 Days)	1,718,597

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Microbio had revenue of TWD 1.81 billion and -1.34 billion in losses. Loss per share was -2.28.

Revenue	1.81B
Gross Profit	714.97M
Operating Income	-411.29M
Pretax Income	-1.50B
Net Income	-1.34B
EBITDA	-306.46M
EBIT	-411.29M
Loss Per Share	-2.28

Balance Sheet

The company has 2.52 billion in cash and 571.72 million in debt, giving a net cash position of 1.94 billion or 3.31 per share.

Cash & Cash Equivalents	2.52B
Total Debt	571.72M
Net Cash	1.94B
Net Cash Per Share	3.31
Equity (Book Value)	10.42B
Book Value Per Share	15.60
Working Capital	2.39B

Cash Flow

In the last 12 months, operating cash flow was 749.23 million and capital expenditures -39.53 million, giving a free cash flow of 709.71 million.

Operating Cash Flow	749.23M
Capital Expenditures	-39.53M
Free Cash Flow	709.71M
FCF Per Share	1.21

Margins

Gross margin is 39.44%, with operating and profit margins of -22.69% and -73.91%.

Gross Margin	39.44%
Operating Margin	-22.69%
Pretax Margin	-82.97%
Profit Margin	-73.91%
EBITDA Margin	-16.90%
EBIT Margin	-22.69%
FCF Margin	39.15%

Dividends & Yields

Microbio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.12%
Shareholder Yield	n/a
Earnings Yield	-9.63%
FCF Yield	5.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 29, 2024. It was a forward split with a ratio of 1.049999998.

Last Split Date	Aug 29, 2024
Split Type	Forward
Split Ratio	1.049999998

Scores

Microbio has an Altman Z-Score of 6.58 and a Piotroski F-Score of 4.

Altman Z-Score	6.58
Piotroski F-Score	4